Open Access · CC BY 4.0
Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?
Journal of Case Reports and Reviews in Medicine · 2025
DOI: 10.64978/jcrrm-0115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Case Reports and Reviews in Medicine, 2025. Verfasst von Akhil Santhosh und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Santhosh, A., & Sreenath, N. (2025). Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?. Journal of Case Reports and Reviews in Medicine. https://doi.org/10.64978/jcrrm-0115
Vancouver
Santhosh A, Sreenath N. Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?. Journal of Case Reports and Reviews in Medicine. 2025. doi:10.64978/jcrrm-0115
BibTeX
@article{Santhosh2025,
author = {Santhosh, Akhil and Sreenath, Nihanthy},
title = {Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?},
journal = {Journal of Case Reports and Reviews in Medicine},
year = {2025},
doi = {10.64978/jcrrm-0115}
}
EUVIMED